| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |